Provided by Tiger Trade Technology Pte. Ltd.

Innoviva

21.14
+0.09000.43%
Post-market: 21.14-0.0025-0.01%19:30 EDT
Volume:1.44M
Turnover:30.35M
Market Cap:1.53B
PE:4.91
High:21.18
Open:20.93
Low:20.85
Close:21.05
52wk High:25.15
52wk Low:16.52
Shares:72.25M
Float Shares:69.02M
Volume Ratio:1.53
T/O Rate:2.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.30
EPS(LYR):3.30
ROE:36.68%
ROA:6.95%
PB:1.24
PE(LYR):6.41

Loading ...

Armata Says FDA Grants Breakthrough Therapy Designation for AP-SA02 in Complicated Staph Aureus Bacteremia

Reuters
·
Sep 14

Armata Pharmaceuticals CEO Deborah Birx Presents at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 10

Armata Says Inhaled Phage Candidate AP-PA02 Completes Phase 2 Trials in Cystic Fibrosis, Bronchiectasis Patients

Reuters
·
Sep 03

Innoviva Management Participates in Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02

Innoviva (INVA) Faces A Valuation Test, Is The Discount Too Wide?

Simply Wall St.
·
Aug 26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Innoviva (INVA) and Pfizer (PFE)

TIPRANKS
·
Aug 21

Basilea Publishes Investor Presentation on Anti-Infectives Strategy and Pipeline Progress

Reuters
·
Aug 18

Innoviva management to meet virtually with Cantor Fitzgerald

TIPRANKS
·
Aug 17

Armata Swings to FY26 Q2 Net Income of $74.14 Million; Operating Loss Widens to $10.31 Million

Reuters
·
Aug 13

Does Innoviva’s Q2 Loss and Buyback-Fueled EPS Shift Change The Bull Case For INVA?

Simply Wall St.
·
Aug 08

Innoviva, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Innoviva Q2 EPS $(1.14) Misses $0.40 Estimate, Sales $119.600M Beat $110.985M Estimate

Benzinga Earnings
·
Aug 06

Innoviva Q2 FY26 Swings to Net Loss of $83.4 Million; Revenue Rises 19% to $119.6 Million

Reuters
·
Aug 06

Innoviva Q2 Royalty Revenue USD 56.334 Million

Reuters
·
Aug 06

Basilea Publishes Investor Presentation on Anti-Infectives Strategy, Pipeline and Hospital Brands Cresemba, Zevtera

Reuters
·
Aug 05

Basilea Publishes Investor Presentation on Hospital Anti-infectives Portfolio and Pipeline

Reuters
·
Jul 29

Armata Pharmaceuticals Names David House CFO

Reuters
·
Jul 20

Armata Pharmaceuticals Announces Press Release Availability

Reuters
·
Jul 13

Armata Wins FDA Agreement on Pediatric Study Plan for Ap-sa02 in Complicated S. Aureus Bacteremia

Reuters
·
Jul 13

Basilea Publishes Investor Presentation on Anti-infectives Strategy, Pipeline Focus

Reuters
·
Jun 30